Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital

키워드

참고문헌 (20)

1. Lautenbach E, "Enterococcal bacteremia:risk factors for vancomycin resistance and predictors of mortality", Infect Control Hosp Epidemiol, 20, pp.318~323 (1999)
2. DiazGranados CA, "Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection", J Infect Dis, 191, pp.588~595 (2005)
3. Ramsey AM, "Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006", Infect Control Hosp Epidemiol, 30, pp.184~186 (2009)
4. Yeh KM, "Vancomycin-resistant enterococcus (VRE) carriage and infection in intensive care units", Microb Drug Resist, 10, pp.177~183 (2004)
5. Dobbs TE, "Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center", J Clin Microbiol, 44, pp.3368~3370 (2006)
6. Fang H, "Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates", Eur J Clin Microbiol Infect Dis, 31, pp.3073~3077 (2012)
7. Performance standards for antimicrobial susceptibility testing; Twenty-third informational supplement, "Clinical and Laboratory Standards Institute", CLSI, ~, pp.CLSI Document M100-S23 (2013)
8. Henwood CJ, "Susceptibility of gram-positive cocci from 25UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group", J Antimicrob Chemother, 46, pp.931~940 (2000)
9. Conceição N, "Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study", Rev Soc Bras Med Trop, 44, pp.177~181 (2011)
10. Arias CA, "Antibiotic-resistant bugs in the 21st century--a clinical super-challenge", N Engl J Med, 360, pp.439~443 (2009)
11. Bourdon N, "Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08", J Antimicrob Chemother, 66, pp.713~721 (2011)
12. Damani A, "A newly described vancomycin-resistant ST412 Enterococcus faecium predominant in Greek hospitals", Eur J Clin Microbiol Infect Dis, 29, pp.329~331 (2010)
13. Protonotariou E, "Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007", J Hosp Infect, 75, pp.225~227 (2010)
14. Deshpande LM, "Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program", Diagn Microbiol Infect Dis, 58, pp.163~170 (2007)
15. Sun Y, "The emergence of clinical resistance to tigecycline", Int J Antimicrob Agents, 41, pp.110~116 (2013)
16. 하남주, "Antimicrobial Activity of Mupirocin, Daptomycin, Linezolid, Quinupristin", Dalfopristin and Tigecycline against Vancomycin-Resistant Enterococci (VRE)from Clinical Isolates in Korea (1998 and 2005), 2007, pp.40(6), 881~887[DOI]
17. Tsai HY, "Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In vitro Surveillance in Taiwan (TIST) study, 2006 to 2010", Antimicrob Agents Chemother, 56, pp.3402~3405 (2012)
18. Stefani S, "Longitudinal assessment of antimicrobial susceptibility among Gram-negative and Gram-positive organisms collected from Italy as part of the tigecycline evaluation and surveillance trial between 2004 and 2011", Pharmaceuticals (Basel), 6, pp.1381~1406 (2013)
19. Sader HS, "Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)", BMC Infect Dis, 7, pp.29~ (2007)
20. Johnson AP, "Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid", Int J Antimicrob Agents, 24, pp.315~319 (2004)

관련 논문AI추천